Authors: Gonzalez, S. A.¹; Fiel, M. I.²; Sauk, J.¹; Canchis, P. W.¹; Liu, R.-C.; Chiriboga, L.³; Yee, H. T.³; Jacobson, I. M.¹; Talal, A. H.¹

Source: Journal of Viral Hepatitis, Volume 16, Number 2, February 2009 , pp. 141-148(8)

Publisher: Wiley-Blackwell

Abstract:

Summary. 

Perisinusoidal hepatic stellate cells (HSC) are the principal fibrogenic cells in the liver. In animal models, HSC apoptosis is the predominant clearance mechanism of activated HSC, although data evaluating whether the same processes occur in humans are limited. We conducted a cross-sectional study to evaluate the association between HSC apoptosis and fibrosis stage in subjects with chronic hepatitis C virus (HCV) infection (n = 44) and HCV-negative controls with normal liver histology (n = 9). We used immunohistochemical techniques to identify activated (α-smooth muscle actin⁺), proliferative (Ki-67⁺) and apoptotic (terminal deoxynucleotidyl transferase [TdT]-mediated dUTP nick end-labelling⁺) HSC in liver biopsy specimens from all subjects. The same pathologist enumerated positive cells per high-power field (HPF, ×200) in 20 periportal/lobular areas. HSC apoptosis was decreased in HCV-positive subjects compared with controls (median 0.4, range 0.0-3.1 vs 1.1, 0.2-3.5 cells/HPF, P = 0.02). Among HCV-positive subjects, HSC apoptosis was decreased in those with moderate to advanced fibrosis (P = 0.04) compared with those with mild fibrosis. By multivariate analysis, HSC apoptosis decreased by an average of 0.14 cells/HPF (95% confidence interval 0.01-0.28 cells/HPF) per increase in fibrosis stage (P = 0.04). While the number of activated and proliferative HSC was significantly increased in HCV-infected subjects compared with that in uninfected controls, the numbers of these cells did not differ between HCV-infected subjects with mild vs moderate/advanced fibrosis. In conclusion, the number of apoptotic HSC was significantly decreased in HCV-infected subjects with advanced fibrosis. In chronic HCV infection, inhibition of HSC apoptosis may be one mechanism by which fibrosis progresses.

Keywords: activation; hepatic stellate cell; inflammation; liver; proliferation

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1365-2893.2008.01052.x

Affiliations: 1: Center for the Study of Hepatitis C and Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York 2: Department of Pathology, Mount Sinai School of Medicine, New York 3: Department of Pathology, New York University School of Medicine, New York, USA

Publication date: 2009-02-01

Related content

• In this: publication
• By this: publisher
• In this Subject: Gastroenterology
• By this author: Gonzalez, S. A. ;  Fiel, M. I. ;  Sauk, J. ;  Canchis, P. W. ;  Liu, R.-C. ;  Chiriboga, L. ;  Yee, H. T. ;  Jacobson, I. M. ;  Talal, A. H.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers